# Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients

> **NCT00071552** · PHASE4 · TERMINATED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Qvar
- **DRUG:** Flovent Diskus

## Key facts

- **NCT ID:** NCT00071552
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01-31
- **Primary completion:** 2006-07-31
- **Final completion:** 2006-07-31
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Very poor enrollment
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071552, "Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00071552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*